Concepedia

Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors

Ιoannis Iakovou, George Dangas, Roxana Mehran, Alexandra J. Lansky, Yoshio Kobayashi, Milena Adamian, Sotir Polena, M Collins, Gary S. Roubin, Gregg W. Stone,

The American Journal of Cardiology · 2002 · 26 citations · 18 references

DOI

Concepts

References

18

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.2K citations · Full text

, , +15

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

The EPILOG Investigators · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

New England Journal of Medicine · 1998 · 1.4K citations · Full text

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

T Epistent Investigators · The Lancet · 1998 · 1.4K citations

, , +9